Literature DB >> 14634067

RhoA activation promotes transendothelial migration of monocytes via ROCK.

Henk Honing1, Timo K van den Berg, Susanne M A van der Pol, Christine D Dijkstra, Rob A van der Kammen, John G Collard, Helga E de Vries.   

Abstract

Monocyte infiltration into inflamed tissue requires the initial arrest of the cells on the endothelium followed by firm adhesion and their subsequent migration. Migration of monocytes and other leukocytes is believed to involve a coordinated remodeling of the actin cytoskeleton. The small GTPases RhoA, Rac1, and Cdc42 are critical regulators of actin reorganization. In this study, we have investigated the role of Rho-like GTPases RhoA, Rac1, and Cdc42 in the adhesion and migration of monocytes across brain endothelial cells by expressing their constitutively active or dominant-negative constructs in NR8383 rat monocytic cells. Monocytes expressing the active form of Cdc42 show a reduced migration, whereas Rac1 expression did not affect adhesion or migration. In contrast, expression of the active form of RhoA in monocytes leads to a dramatic increase in their adhesion and migration across endothelial cells. The effect of RhoA was found to be mediated by its down-stream effector Rho kinase (ROCK), as pretreatment with the selective ROCK inhibitor Y-27632 prevented this enhanced adhesion and migration. These results demonstrate that RhoA activation in monocytes is sufficient to enhance adhesion and migration across monolayers of endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634067     DOI: 10.1189/jlb.0203054

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  36 in total

Review 1.  Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.

Authors:  M Oka; K A Fagan; P L Jones; I F McMurtry
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

2.  Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at leading edges polarizes neutrophils.

Authors:  Kun Gao; Wenwen Tang; Yuan Li; Pingzhao Zhang; Dejie Wang; Long Yu; Chenji Wang; Dianqing Wu
Journal:  J Cell Sci       Date:  2015-01-14       Impact factor: 5.285

3.  Involvement of Rho kinase (ROCK) in sepsis-induced acute lung injury.

Authors:  Ismail Cinel; Mustafa Ark; Phillip Dellinger; Tuba Karabacak; Lulufer Tamer; Leyla Cinel; Paul Michael; Shaimaa Hussein; Joseph E Parrillo; Anand Kumar; Aseem Kumar
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

4.  Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

Authors:  Nadezhda Glezeva; Patrick Collier; Victor Voon; Mark Ledwidge; Kenneth McDonald; Chris Watson; John Baugh
Journal:  J Cardiovasc Transl Res       Date:  2013-04-27       Impact factor: 4.132

5.  A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats.

Authors:  In-Young Choi; Jae-Chul Lee; Chung Ju; Sunyoung Hwang; Geum-Sil Cho; Hyuk Woo Lee; Won Jun Choi; Lak Shin Jeong; Won-Ki Kim
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

6.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Signaling through Rho GTPase pathway as viable drug target.

Authors:  Qun Lu; Frank M Longo; Huchen Zhou; Stephen M Massa; Yan-Hua Chen
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation.

Authors:  Sandra B Haudek; Damon Gupta; Oliver Dewald; Robert J Schwartz; Lei Wei; JoAnn Trial; Mark L Entman
Journal:  Cardiovasc Res       Date:  2009-04-30       Impact factor: 10.787

9.  Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  Andrea Lopez-Lopez; Carmen M Labandeira; Jose L Labandeira-Garcia; Ana Muñoz
Journal:  Br J Pharmacol       Date:  2020-11-03       Impact factor: 8.739

10.  Lysophosphatidic acid-induced RhoA signaling and prolonged macrophage infiltration worsens fibrosis and fatty infiltration following rotator cuff tears.

Authors:  Michael R Davies; Lawrence Lee; Brian T Feeley; Hubert T Kim; Xuhui Liu
Journal:  J Orthop Res       Date:  2016-08-19       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.